Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

    Investing

    • Inheritance TaxInheritance Tax
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Market News - Page 54

10 December 2024

GSK plc Overall Survival Data for Blenrep

Released 18:29:00 09 December 2024 Blenrep shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse GSK…

10 December 2024

Games Workshop Group plc Announces Agreement With Amazon

Games Workshop Group PLC (“Games Workshop” or the “Company”) Agreement with Amazon for films and television series Further to its announcement on 18 December…

10 December 2024

Prudential Considers Minority Sale in Eastspring Investments

Prudential Plc is considering options for its asset manager Eastspring Investments that include selling a minority stake to help broaden the business, according to…

9 December 2024

James Cropper Announces Collaboration with Oxford University

James Cropper plc (“James Cropper”, the “Company” or the “Group”) Collaboration with Oxford University James Cropper Advanced Materials and Oxford University Secure Prestigious Grant…

9 December 2024

GSK plc Blenrep Combination China Filing Acceptance

Blenrep (belantamab mafodotin) combination accepted for priority review in China in relapsed/refractory multiple myeloma GSK plc (LSE/NYSE: GSK) today announced that the National Medical Products…

9 December 2024

GSK plc Nucala COPD Submission Accepted by FDA

US FDA accepts GSK’s submission for the use of Nucala (mepolizumab) in COPD GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA)…

6 December 2024

James Halstead AGM Statement

JAMES HALSTEAD PLC Chairman’s Statement to the Annual General Meeting James Halstead plc, UK manufacturer and global seller of commercial flooring, is holding its…

6 December 2024

Keystone Positive Change Investment Trust plc Proposals for IT Reconstruction

Keystone Positive Change Investment Trust plc Publication of Circular Recommended proposals for the reconstruction and voluntary winding up of the Company Introduction On 30…

Posts navigation

  • «
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 874
  • »

Home > Market News > Page 54

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.dev.icgonline.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG